Patent Assignment
Reel/Frame 061083/0062
Assignment of Assignor's Interest
Recorded: 2022-09-13
Pages: 6
Assignors
FRANK, MICHAEL
Executed: 2020-01-27
JEUNEMAITRE, XAVIER
Executed: 2020-01-27
BENACHI, ALEXANDRA
Executed: 2020-01-27
Assignees
ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (AP-HP)
3 AVENUE VICTORIA, PARIS, 75004, FRANCE
UNIVERSITÉ PARIS DESCARTES
12 RUE DE L'ECOLE DE MEDECINE, PARIS, 75006, FRANCE
Covered Properties
(2)
Use of Celiprolol for Treating Vascular Ehlers-Danlos Syndrome in Women During Pregnancy and Peripartum Period
Application:
16/184,903 →
Publication:
US 2019/0192456
Use of Celiprolol for Treating Vascular Ehlers-Danlos Syndrome in Women During Pregnancy and Peripartum Period
Application:
16/879,511 →
Publication:
US 2021/0137859
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Mar 11, 2022
From: ACER THERAPEUTICS INC.
To: SWK FUNDING LLC
Reel/Frame 059237/0638 →
Change of Name
Jun 20, 2022
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 060390/0122 →
Merger and Change of Name
Jun 20, 2022
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7; UNIVERSITE DE PARIS
To: UNIVERSITE DE PARIS
Reel/Frame 060541/0336 →
Corrective Assignment to Correct the Property Number 16930208 Previously Recorded at Reel: 060390 Frame: 0122. Assignor(S) Hereby Confirms the Change of Name.
Jan 11, 2023
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 062387/0489 →
Corrective Assignment to Correct the Property Number 16930208 Previously Recorded at Reel: 060541 Frame: 0336. Assignor(S) Hereby Confirms the Merger and Change of Name.
Jan 11, 2023
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE DE PARIS
Reel/Frame 062387/0346 →
Security Interest
Jul 6, 2023
From: SWK FUNDING LLC; ACER THERAPEUTICS INC
To: NANTAHALA CAPITAL MANAGEMENT, LLC
Reel/Frame 064167/0828 →
Release of Security Interest
Apr 5, 2024
From: ZEVRA THERAPEUTICS INC. (AS SUCCESSOR IN INTEREST TO NANTAHALA CAPITAL MANAGEMENT, LLC, AS SUCCESSOR IN INTEREST TO SWK FUNDING LLC)
To: ACER THERAPEUTICS INC.
Reel/Frame 067020/0036 →